Ratings by Baird (Eric Coldwell)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2026 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | Medline Inc | MDLN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2026 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2026 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2026 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2026 | Medpace | MEDP | Upgrade | Outperform (Neutral) |
530.35 (470.59) |
-11.27% | Details | |
| 2/6/2026 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2026 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/14/2026 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/14/2026 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 1/14/2026 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/14/2026 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2026 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2026 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2026 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Outperform (N/A) |
41.25 (43.83) |
6.25% | Details | |
| 1/6/2026 | Accendra Health | ACH | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 12/3/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2025 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/18/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/18/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2025 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Charles River Labs | CRL | Upgrade | Outperform (Neutral) |
177.85 (174.46) |
-1.91% | Details | |
| 11/5/2025 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | IQVIA Holdings | IQV | Upgrade | Outperform (Neutral) |
217.43 (174.49) |
-19.75% | Details | |
| 10/24/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2025 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2025 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2025 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2025 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 10/9/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 9/15/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 9/15/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 9/15/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 9/3/2025 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 9/2/2025 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | Quest Diagnostics | DGX | Downgrade | Neutral (Outperform) |
183.72 (199.21) |
8.43% | Details | |
| 8/20/2025 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 8/13/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2025 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2025 | Fortrea | FTRE | Upgrade | Outperform (Neutral) |
5.74 (9.61) |
67.42% | Details | |
| 7/25/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/24/2025 | ICON plc | ICLR | Upgrade | Outperform (Neutral) |
161.50 (107.20) |
-33.62% | Details | |
| 7/23/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 7/23/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 6/17/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 6/17/2025 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 6/17/2025 | Fortrea | FTRE | Maintain | Neutral (N/A) |
|
Details | ||
| 6/13/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2025 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2025 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/28/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/28/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/19/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2025 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2025 | Fortrea | FTRE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2025 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 4/23/2025 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/11/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/11/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2025 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2025 | Fortrea | FTRE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2025 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/17/2025 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2025 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Fortrea | FTRE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2025 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2025 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2025 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 2/21/2025 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 2/18/2025 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2025 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 2/6/2025 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2025 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2025 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/4/2025 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 1/31/2025 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2025 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 1/27/2025 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 1/21/2025 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 12/11/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2024 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2024 | Fortrea | FTRE | Downgrade | Neutral (Outperform) |
23.73 (5.74) |
-75.81% | Details | |
| 11/25/2024 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2024 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2024 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/25/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 11/25/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2024 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2024 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/20/2024 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2024 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2024 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2024 | McKesson | MCK | Upgrade | Outperform (Neutral) |
525.28 (919.26) |
75% | Details | |
| 11/7/2024 | Cencora Inc | COR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2024 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2024 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2024 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 11/1/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2024 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2024 | ICON plc | ICLR | Downgrade | Neutral (Outperform) |
283.49 (161.50) |
-43.03% | Details | |
| 10/23/2024 | Medpace | MEDP | Downgrade | Neutral (Outperform) |
352.92 (530.35) |
50.27% | Details | |
| 10/23/2024 | Quest Diagnostics | DGX | Upgrade | Outperform (Neutral) |
147.37 (183.72) |
24.67% | Details | |
| 9/24/2024 | Catalent | CTLT | Downgrade | Neutral (Outperform) |
60.00 (63.48) |
5.8% | Details | |
| 9/24/2024 | McKesson | MCK | Downgrade | Neutral (Outperform) |
508.00 (525.28) |
3.4% | Details | |
| 9/23/2024 | Owens & Minor | OMI | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/23/2024 | AdaptHealth | AHCO | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/23/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/20/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 9/20/2024 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/20/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 9/20/2024 | ICON plc | ICLR | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/20/2024 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 9/6/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/21/2024 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 8/15/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2024 | Fortrea | FTRE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 7/16/2024 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 7/10/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 7/9/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 7/9/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/5/2024 | Quest Diagnostics | DGX | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/25/2024 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 6/13/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 5/31/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2024 | Fortrea | FTRE | Upgrade | Outperform (Neutral) |
33.03 (23.73) |
-28.16% | Details | |
| 5/8/2024 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2024 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/26/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/10/2024 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 4/5/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 4/5/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 4/3/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2024 | Fortrea | FTRE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/22/2024 | Fortrea | FTRE | New Coverage | Neutral (N/A) |
40.01 (9.61) |
-75.98% | Details | |
| 3/11/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/7/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2024 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 2/14/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2024 | Catalent | CTLT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/8/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2024 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/2/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/2/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2024 | Science 37 | SNCE | Downgrade | Neutral (Outperform) |
4.74 (5.75) |
21.31% | Details | |
| 1/18/2024 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 1/17/2024 | Medpace | MEDP | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2024 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2024 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/10/2024 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 12/4/2023 | IQVIA Holdings | IQV | Maintain | Neutral (N/A) |
|
Details | ||
| 12/4/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/16/2023 | Catalent | CTLT | Upgrade | Outperform (Neutral) |
35.53 (60.00) |
68.87% | Details | |
| 11/15/2023 | Science 37 | SNCE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2023 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2023 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2023 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2023 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2023 | IQVIA Holdings | IQV | Downgrade | Neutral (Outperform) |
180.83 (217.43) |
20.24% | Details | |
| 10/26/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/24/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 10/24/2023 | Medpace | MEDP | Upgrade | Outperform (Neutral) |
229.25 (352.92) |
53.95% | Details | |
| 10/17/2023 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/17/2023 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/17/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2023 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2023 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/7/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2023 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 8/16/2023 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Science 37 | SNCE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2023 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2023 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2023 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2023 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 7/14/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 7/13/2023 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/12/2023 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 7/12/2023 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/12/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/6/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/3/2023 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/3/2023 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 6/9/2023 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Syneos | SYNH | Downgrade | Neutral (Outperform) |
38.45 (42.98) |
11.78% | Details | |
| 5/10/2023 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2023 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2023 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2023 | Premier, Inc. | PINC | Downgrade | Neutral (Outperform) |
33.41 (28.26) |
-15.41% | Details | |
| 5/1/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2023 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/18/2023 | Premier, Inc. | PINC | Maintain | Outperform (N/A) |
|
Details | ||
| 4/13/2023 | Science 37 | SNCE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2023 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2023 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 3/15/2023 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/7/2023 | Science 37 | SNCE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | AdaptHealth | AHCO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2023 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2023 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2023 | Cardinal Health | CAH | Upgrade | Outperform (Neutral) |
75.72 (217.78) |
187.61% | Details | |
| 2/2/2023 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/2/2023 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2023 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/11/2023 | Premier, Inc. | PINC | Maintain | Outperform (N/A) |
|
Details | ||
| 1/11/2023 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/11/2023 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2023 | Cardinal Health | CAH | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2022 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2022 | Premier, Inc. | PINC | Upgrade | Outperform (Neutral) |
34.88 (28.26) |
-18.98% | Details | |
| 10/27/2022 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2022 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/12/2022 | Owens & Minor | OMI | Downgrade | Neutral (Outperform) |
23.22 (2.80) |
-87.94% | Details | |
| 4/1/2022 | Walgreens Boosts Alliance | WBA | Downgrade | Neutral (Outperform) |
47.46 (11.98) |
-74.76% | Details | |
| 1/11/2022 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2021 | Science 37 | SNCE | New Coverage | Outperform (N/A) |
9.01 (5.75) |
-36.18% | Details | |
| 7/14/2021 | AdaptHealth | AHCO | Upgrade | Outperform (Neutral) |
26.50 (9.49) |
-64.19% | Details | |
| 7/2/2021 | Walgreens Boosts Alliance | WBA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/27/2021 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2021 | Cardinal Health | CAH | Downgrade | Neutral (Outperform) |
56.54 (217.78) |
285.18% | Details | |
| 5/7/2021 | AdaptHealth | AHCO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2021 | CVS Health | CVS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/23/2021 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2021 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/20/2021 | PRA Health Sciences | PRAH | Downgrade | Neutral (Outperform) |
161.76 (165.21) |
2.13% | Details | |
| 4/15/2021 | PPD Inc. | PPD | Downgrade | Neutral (Outperform) |
43.00 (47.30) |
10% | Details | |
| 4/13/2021 | AdaptHealth | AHCO | Downgrade | Neutral (Outperform) |
36.99 (9.49) |
-74.34% | Details | |
| 3/12/2021 | Quest Diagnostics | DGX | Downgrade | Neutral (Outperform) |
116.87 (199.21) |
70.45% | Details | |
| 3/8/2021 | ICON plc | ICLR | Upgrade | Outperform (Neutral) |
172.01 (283.49) |
64.81% | Details | |
| 1/11/2021 | Walgreens Boosts Alliance | WBA | Upgrade | Outperform (Neutral) |
45.26 (11.98) |
-73.53% | Details | |
| 12/8/2020 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2020 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2020 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2020 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/21/2020 | PPD Inc. | PPD | Maintain | (N/A) |
|
Details | ||
| 8/12/2020 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 8/6/2020 | PPD Inc. | PPD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2020 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/21/2020 | Owens & Minor | OMI | Upgrade | Outperform (Neutral) |
7.94 (23.22) |
192.44% | Details | |
| 7/20/2020 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 7/20/2020 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2020 | Medpace | MEDP | Upgrade | Neutral (Underperform) |
88.47 (470.59) |
431.92% | Details | |
| 6/4/2020 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/4/2020 | Syneos | SYNH | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2020 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | PPD Inc. | PPD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | AmerisourceBergen | ABC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | CVS Health | CVS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2020 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2020 | Owens & Minor | OMI | Downgrade | Neutral (Outperform) |
7.36 (2.80) |
-61.96% | Details | |
| 5/4/2020 | PRA Health Sciences | PRAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2020 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/20/2020 | Medpace | MEDP | Downgrade | Underperform (Neutral) |
82.31 (470.59) |
471.73% | Details | |
| 4/20/2020 | ICON plc | ICLR | Downgrade | Neutral (Outperform) |
156.29 (107.20) |
-31.41% | Details | |
| 4/13/2020 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 4/13/2020 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/9/2020 | McKesson | MCK | Maintain | Outperform (N/A) |
|
Details | ||
| 4/9/2020 | Cardinal Health | CAH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2020 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2020 | Walgreens Boosts Alliance | WBA | Maintain | Neutral (N/A) |
|
Details | ||
| 4/1/2020 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2020 | CVS Health | CVS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/5/2020 | Owens & Minor | OMI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2020 | PPD Inc. | PPD | New Coverage | Outperform (N/A) |
35.18 (47.30) |
34.45% | Details | |
| 2/21/2020 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2020 | PRA Health Sciences | PRAH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2020 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2020 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2020 | CVS Health | CVS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2020 | McKesson | MCK | Upgrade | Outperform (Neutral) |
152.15 (508.00) |
233.88% | Details | |
| 2/7/2020 | Cardinal Health | CAH | Upgrade | Outperform (Neutral) |
52.68 (217.78) |
313.4% | Details | |
| 2/7/2020 | AmerisourceBergen | ABC | Upgrade | Outperform (Neutral) |
91.44 (179.98) |
96.83% | Details | |
| 2/5/2020 | Premier, Inc. | PINC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/5/2020 | McKesson | MCK | Maintain | Neutral (N/A) |
|
Details | ||
| 1/31/2020 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2020 | Owens & Minor | OMI | Upgrade | Outperform (Neutral) |
5.79 (2.80) |
-51.64% | Details | |
| 1/16/2020 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | Walgreens Boosts Alliance | WBA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2019 | Premier, Inc. | PINC | Downgrade | Neutral (Outperform) |
37.35 (28.26) |
-24.34% | Details | |
| 11/7/2019 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2019 | AmerisourceBergen | ABC | Maintain | Neutral (N/A) |
|
Details | ||
| 7/25/2019 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/25/2019 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2019 | PRA Health Sciences | PRAH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2019 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2019 | Medpace | MEDP | Maintain | Neutral (N/A) |
|
Details | ||
| 4/24/2019 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2019 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/2/2019 | Walgreens Boosts Alliance | WBA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/28/2019 | Walgreens Boosts Alliance | WBA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2019 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2019 | Walgreens Boosts Alliance | WBA | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/28/2019 | PRA Health Sciences | PRAH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2019 | CVS Health | CVS | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/21/2019 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | Owens & Minor | OMI | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/15/2019 | Quest Diagnostics | DGX | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/5/2019 | Premier, Inc. | PINC | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2019 | McKesson | MCK | Maintain | Neutral (N/A) |
|
Details | ||
| 1/31/2019 | AmerisourceBergen | ABC | Maintain | Neutral (N/A) |
|
Details | ||
| 12/7/2018 | Diplomat Pharmacy | DPLO | Upgrade | Neutral (Underperform) |
15.72 (4.00) |
-74.55% | Details | |
| 11/30/2018 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/29/2018 | Quest Diagnostics | DGX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Diplomat Pharmacy | DPLO | Downgrade | Underperform (Neutral) |
20.03 (15.72) |
-21.52% | Details | |
| 11/1/2018 | Express Scripts | ESRX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2018 | Owens & Minor | OMI | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2018 | McKesson | MCK | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2018 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2018 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2018 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/12/2018 | Walgreens Boosts Alliance | WBA | Maintain | Neutral (N/A) |
|
Details | ||
| 10/2/2018 | Cardinal Health | CAH | Maintain | Neutral (N/A) |
|
Details | ||
| 10/2/2018 | PRA Health Sciences | PRAH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2018 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2018 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2018 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2018 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details |
